MECOM Locus classical transcript isoforms affect tumor immune microenvironment and different targets in ovarian cancer
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.The MECOM gene
Area Of Science
- Oncology
- Genomics
- Immunology
Background
- The MECOM locus is frequently amplified in high-grade serous ovarian carcinoma (HGSOC).
- Research on MECOM transcripts' role in HGSOC prognosis and the tumor immune microenvironment (TIME) is limited.
- Understanding MECOM's impact is crucial for HGSOC patient outcomes.
Purpose Of The Study
- To investigate the association between MECOM transcript expression, patient survival, and TIME modulation in HGSOC.
- To identify specific MECOM isoforms and their regulatory roles.
- To explore MECOM as a potential therapeutic target in ovarian cancer.
Main Methods
- Analysis of MECOM transcript expression in 352 HGSOC patients and 88 normal ovarian tissues (GTEx/TCGA database).
- Utilized bioinformatics tools (UCSC Genome Browser, Ensembl, NextProt) to identify MECOM isoforms.
- Employed Cox regression, Kaplan-Meier curves, and TIME evaluation algorithms.
- Analyzed ChIP-seq and RNA-seq data for regulatory target identification.
Main Results
- Elevated MECOM isoform transcripts correlated with poorer HGSOC survival, potentially via cancer-associated fibroblasts (CAFs) and immunosuppressive cells.
- Higher EVI1 isoform transcripts linked to improved survival, associated with CD8+ T cells, macrophages, and reduced JUN activity.
- MECOM isoforms differentially impact ovarian cancer survival and tumor development.
Conclusions
- MECOM isoforms have distinct roles in HGSOC pathogenesis and patient prognosis.
- Targeting MECOM splice variants may offer novel therapeutic strategies for ovarian cancer.
- Further investigation into MECOM's molecular mechanisms is essential for drug development.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...